High cholesterol can cause the arteries to harden and narrow, making it more difficult for blood to flow. In some cases, it ...

Around two in five people in the UK are thought to be living with high cholesterol, which is often dubbed a "silent killer".

Ophthalmology Times - ophthalmology news, articles, and events in a timely and accurate manner for members of the ophthalmic ...

A lesser-known indicator of high cholesterol could manifest in the eye, signalling an excess of cholesterol in the ...

Berlin: Bayer has submitted an application to the Japanese Ministry of Health, Labour and Welfare (MHLW) seeking approval of ...

The Cleveland Clinic has pointed out that high cholesterol could potentially result in retinal vein occlusion (RVO), a ...

for aflibercept injection 8mg for the treatment of macular edema following retinal vein occlusion (RVO) and monthly dosing across all approved indications. The sBLA was supported by data from the ...

In this expert perspective, Manjot K. Gill, MD, discusses faricimab for the management of retinal vein occlusion. Gill, vice chair of clinical performance and ophthalmology professor at ...

The Cleveland Clinic has pointed out that high cholesterol could potentially result in retinal vein occlusion (RVO), a condition marked by "painless" blurring or vision loss in one eye.

EYLEA HD is a treatment for retinal vein occlusion (RVO) that allows for dosing every 8 weeks after initial monthly doses, potentially halving injections. What is the FDA's action date for EYLEA ...

Regulatory action was based on data from the Phase III QUASAR trial, which demonstrated that Eylea HD dosed every eight weeks achieved non-inferior visual acuity outcomes compared to Eylea in patients ...